GlassScriptPhysician profile
Mayuri H Patel
NPI 1821265422
$3,705.51
in general payments reported to CMS, 2019-2025
26 companies · $386 in 2025
The $386 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2020: $533 · 2021: $1,060 · 2022: $325 · 2023: $583 · 2024: $186 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,154.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $703.94 | 2019-2025 | Watchman Flx |
| Amgen INC. | $371.98 | 2020-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $280.34 | 2019-2021 | |
| Cardiovascular Systems INC. | $279.47 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $270.68 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $228.58 | 2020-2025 | Jardiance |
| Medtronic, INC. | $220.94 | 2021-2024 | Resolute Onyx |
| Alnylam Pharmaceuticals INC. | $191.67 | 2021-2023 | Onpattro |
| Abiomed | $163.81 | 2021-2025 | Impella |
| Janssen Pharmaceuticals, INC | $132.41 | 2019-2021 | |
| Medtronic Vascular, INC. | $127.77 | 2019-2020 | |
| Cvrx, INC. | $122.89 | 2023 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $111.78 | 2022-2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $103.99 | 2021-2024 | |
| Lantheus Medical Imaging, INC. | $70.29 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $65.46 | 2025 | |
| Pfizer INC. | $58.01 | 2022-2025 | |
| Cardinal Health 200 LLC | $47.70 | 2019-2020 | |
| Amarin Pharma, INC. | $33.57 | 2020-2021 | |
| Altathera Pharmaceuticals LLC | $25.00 | 2025 | Sotalol Hydrochloride |
| Kestra Medical Technology Services, INC. | $24.94 | 2023 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $18.23 | 2019 | |
| Novo Nordisk INC | $15.18 | 2023 | Ozempic |
| Corcept Therapeutics | $13.07 | 2021 | |
| Ekos Corporation | $12.42 | 2019 | |
| Csl Behring | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayuri Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.